Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphoma: A comparison of doxorubicin and pirarubicin: a randomized phase II study

Author： Tsurumi Hisashi   Yamada Toshiki   Sawada Michio   Kasahara Senji   Kanemura Nobuhiro   Kojima Yasushi   Fukuno Kenji   Hara Takeshi   Saio Masanao   Takahashi Takeshi   Oyama Masami   Ozawa Keiya   Takami Tsuyoshi   Moriwaki Hisataka  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.130, Iss.2, 2004-02, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin's lymphoma

By Wang Wenwu  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 107-110

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Phase I trial of fludarabine and paclitaxel in non-hodgkin’s lymphoma

By Abbasi Muhammad   Sparano Joseph   Sarta Catherine   Wiernik Peter  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 53-58

Humana Press, Inc

Access to resources Recommend Favorite

Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma

By Kilickap Saadettin   Yavuz Bunyamin   Aksoy Sercan   Sahiner Levent   Dincer Murat   Harputluoglu Hakan   Erman Mustafa   Aytemir Kudret   Tokgozoglu Lale   Barista Ibrahim  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 437-442

Humana Press, Inc

Access to resources Recommend Favorite

A phase II trial of adjuvant low-dose total body irradiation in non-hodgkin's lymphoma patients following standard CHOP

By Safwat Akmal   Bayoumi Yasser   Akkoush Hany   Mahmoud Hossam  

Acta Oncologica, Vol. 43, Iss. 5, 2004-07 ,pp. : 480-485

Informa Healthcare

Access to resources Recommend Favorite